World Pharma News / Search results for nexavar

1
Vote

Bayer and Onyx Provide Update on Phase III Trial of Nexavar®

Posted by worldpharmanews 754 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: bayer onyx nexavar

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. announced that a Phase III trial evaluating Nexavar® (sorafenib) tablets in patients with non-small cell lung cancer (NSCLC) was stoppe read more »
Discuss Add this link to... Bury

1
Vote

Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent

Posted by worldpharmanews 666 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: bayer nexavar

Bayer HealthCare and Onyx Pharmaceuticals, Inc. today announced that Nexavar® (sorafenib) tablets significantly improved overall survival by 47.3 percent (HR=0.68; p-value=0.014) in patients in the A read more »
Discuss Add this link to... Bury

1
Vote

Nexavar Study Demonstrates Significant Improvement in Overall Survival

Posted by worldpharmanews 596 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: bayer nexavar

Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of Medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial sh read more »
Discuss Add this link to... Bury

1
Vote

Nexavar Approved for Treatment of Liver Cancer in China

Posted by worldpharmanews 593 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: bayer onyx nexavar

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the State Food and Drug Administration (SFDA) of China has approved Nexavar® (sorafenib) tablets for the treatment read more »
Discuss Add this link to... Bury

1
Vote

New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer

Posted by worldpharmanews 569 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: bayer onyx pharmaceuticals nexavar

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced the start of a Phase III study with Nexavar® (sorafenib) tablets in liver cancer. The randomized, double-blind, placebo read more »
Discuss Add this link to... Bury